cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results
Year Over Year Net Sales Expected to Remain in line with Prior Year Year Over Year Quarterly Net Sales Expected to Increase Between 3% and 5% cbdMD, Inc. (NYSE American: YCBD) (the “Company”) one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehensive line of domestically produced CBD […]